s6y

Vesicor Therapeutics Holdings, Inc.

Ticker
BKHA, BKHAR, BKHAU
CIK
2000775
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Black Hawk Acquisition Corp

Financials 16

  1. 10-Q Quarterly Report for period ending Aug 31, 2026
  2. 10-Q Quarterly Report for period ending May 31, 2026
  3. 10-K/A Annual Report for period ending Nov 30, 2025
  4. 10-Q Quarterly Report for period ending Feb 28, 2026
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Feb 28, 2026
  6. 10-K Annual Report for period ending Nov 30, 2025
  7. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Nov 30, 2025
  8. 10-Q Quarterly Report for period ending Aug 31, 2025
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Aug 31, 2025
  10. 10-Q Quarterly Report for period ending May 31, 2025

All 16 financials filings

News 32

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 32 news filings

Ownership 16

  1. SC 13G/A Major Shareholders
  2. SC 13G Major Shareholders
  3. SC 13G Major Shareholders
  4. SC 13G Major Shareholders
  5. SC 13G Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G Major Shareholders
  8. SC 13D Major Shareholders
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13D Major Shareholders

All 16 ownership filings

Prospectus 21

  1. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. S-4/A Registration of securities issued in business combination transactions
  4. S-4/A Registration of securities issued in business combination transactions
  5. S-4/A Registration of securities issued in business combination transactions
  6. S-4/A Registration of securities issued in business combination transactions
  7. S-4/A Registration of securities issued in business combination transactions
  8. S-4/A Registration of securities issued in business combination transactions
  9. S-4/A Registration of securities issued in business combination transactions
  10. S-4/A Registration of securities issued in business combination transactions

All 21 prospectus filings

Proxies 6

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEFR14A Definitive revised proxy soliciting materials
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

Other 30

  1. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  2. SCHEDULE 13G
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G/A
  7. EFFECT Notice of Effectiveness
  8. DEL AM Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement
  9. SCHEDULE 13G/A
  10. SCHEDULE 13G/A

All 30 other filings